fingolimod richter kõvakapsel
gedeon richter plc. - fingolimood - kõvakapsel - 0,5mg 7tk; 0,5mg 98tk; 0,5mg 28tk
fingolimod stada kõvakapsel
stada arzneimittel ag - fingolimood - kõvakapsel - 0,5mg 7tk; 0,5mg 28tk; 0,5mg 30tk
pylclari
curium pet france - piflufolastat (18f) - eesnäärmevähk - diagnostilised radiofarmatseutilised ühendid - see ravim on mõeldud ainult diagnostiliseks kasutamiseks. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).
fingolimod remedica kõvakapsel
remedica limited - fingolimood - kõvakapsel - 0,5mg 98tk; 0,5mg 28tk; 0,5mg 7tk
hypophysin süstelahus
veyx-pharma gmbh - karbetotsiin - süstelahus - 35mcg 1ml 100ml 1tk; 35mcg 1ml 50ml 1tk; 35mcg 1ml 100ml 12tk; 35mcg 1ml 20ml 1tk
forcyl süstelahus
vetoquinol s.a. - marbofloksatsiin - süstelahus - 160mg 1ml 50ml 1tk; 160mg 1ml 250ml 1tk; 160mg 1ml 100ml 1tk
pamitor 15 mg/ml infusioonilahuse kontsentraat
chiesi pharmaceuticals gmbh - pamidroonhape - infusioonilahuse kontsentraat - 15mg 1ml 6ml 1tk; 15mg 1ml 4ml 1tk; 15mg 1ml 2ml 4tk; 15mg 1ml 1ml 4tk; 15mg 1ml 2ml 1tk; 15mg 1ml 4ml 4tk
masterflox süstelahus
fatro s.p.a. - marbofloksatsiin - süstelahus - 40mg 1ml 250ml 1tk; 40mg 1ml 100ml 1tk; 40mg 1ml 50ml 1tk
hypophysin süstelahus
veyx-pharma gmbh - karbetotsiin - süstelahus - 70mcg 1ml 10ml 1tk; 70mcg 1ml 20ml 1tk; 70mcg 1ml 50ml 12tk; 70mcg 1ml 50ml 1tk
lamisil kreem
glaxosmithkline dungarvan limited - terbinafiin - kreem - 10mg 1g 15g 1tk